A Clinical Study Know the efficacy of Ayurveda Medicines in COVID 19 Positive Patients
Phase 4
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B338- Other specified viral diseases
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Patients positive for COVID 19 confirmed by RT-PCR.
2) Patients with mild to moderate symptoms (NEWS 2 criteria).
Exclusion Criteria
Patients with
1) Diabetes Miletus.
2) Hepatic dysfunction
3) Renal dysfunction
4) Pulmonary dysfunction
5) Cardiovascular disease
6) Debilitating Neurological disorders.
7) Psychiatric illness.
8) Pregnant and Lactating.
9) Oxygen saturation less than 90%.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in <br/ ><br>1) COVID 19 Symptomatology. <br/ ><br>2) RT-PCR <br/ ><br>3) IL-6Timepoint: 2 weeks
- Secondary Outcome Measures
Name Time Method Changes in <br/ ><br>1) Hospital length stay. <br/ ><br>2) Intensive care unit free days. <br/ ><br>3) Oxygen saturation <br/ ><br>4) Hospital Anxiety and depression Scale (HADS)Timepoint: 2 weeks